Nanofiber Solutions

Nanofiber Solutions, founded in 2009, is a private, revenue-generating company developing a novel class of nanofiber-based implants and research tools. Its core technology platform produces 3D scaffolds that mimic the natural extracellular matrix, enabling advanced cell culture for drug discovery and serving as the foundation for off-the-shelf regenerative medicine products. The company has achieved FDA clearances, operates in both human and veterinary markets, and has expanded through subsidiary creation and acquisition, positioning itself at the intersection of medical devices and tissue engineering.

Proprietary three-dimensional nanofiber scaffold technology that mimics the native extracellular matrix (ECM). The platform uses electrospinning and other techniques to create biocompatible, bioresorbable scaffolds with controlled architecture for 3D cell culture and implantable medical devices.

Nanofiber Solutions competes in the broader biomaterials and scaffold market against companies offering decellularized tissues, hydrogels, and 3D-printed structures. Key competitors include large players like Baxter (ACell), Integra LifeSciences, and Smith & Nephew, as well as startups in the 3D cell culture space like Corning (with Transwells) and niche scaffold developers. Its differentiation lies in the specific architectural mimicry of the ECM using nanofibers.